SS
PACB icon

SBI Securities’s Pacific Biosciences PACB Stock Holding History

SBI Securities’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.3K Sell
3,157
-17,827
-85% -$25.9K ﹤0.01% 2150
2026
Q1 		$27.7K Buy
20,984
+15,613
+291% +$27.9K ﹤0.01% 1320
2025
Q4 		$10K Buy
5,371
+1,793
+50% +$3.44K ﹤0.01% 1720
2025
Q3 		$4.58K Sell
3,578
-142
-4% -$192 ﹤0.01% 2084
2025
Q2 		$4.61K Buy
3,720
+211
+6% +$244 ﹤0.01% 2022
2025
Q1 		$4.14K Buy
3,509
+418
+14% +$641 ﹤0.01% 1970
2024
Q4 		$5.66K Buy
+3,091
New +$6.03K ﹤0.01% 1884

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

SBI Securities's PACB Position: Q2 2026 in Review

SBI Securities reduced its Pacific Biosciences (PACB) stake by 85% in Q2 2026, selling an estimated $25.9K and leaving 3,157 shares worth $5.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2150.

SBI Securities first reported a position in PACB in Q4 2024 and has held it in 7 quarters since. The position peaked at $27.7K in Q1 2026. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • SBI Securities held 3,157 shares of Pacific Biosciences worth $5.3K as of Q2 2026.
  • SBI Securities sold 17,827 Pacific Biosciences shares in Q2 2026, an estimated $25.9K.
  • Pacific Biosciences made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2150 holding.
  • SBI Securities first reported a position in Pacific Biosciences in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Pacific Biosciences position peaked at $27.7K in Q1 2026.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.